5-Bromo-2-(trifluoromethoxy)aniline
Grundinformationen
- CAS
886762-08-9- Standard-SMILES
Nc1cc(Br)ccc1OC(F)(F)F- InChIKey
FOJWHUFRHXEUBA-UHFFFAOYSA-N- Summenformel
- C7H5BrF3NO
- Durchschnittliche Molmasse
- 256,02 g/mol
- Monoisotopische Masse
- 254,95066054
Namen und Bezeichner
- Bevorzugter Name
- 5-Bromo-2-(trifluoromethoxy)aniline
- IUPAC
- 5-bromo-2-(trifluoromethoxy)aniline
- Englischer Name
- 5-Bromo-2-(trifluoromethoxy)aniline
- Summenformel
- C7H5BrF3NO
- Molmasse
- 256.02
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
886762-08-9- PubChem CID
- 2779367
- DTXSID
DTXSID90381416- EC Number
- 814-497-4
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 3,1
- Polarare Oberfläche (TPSA)
- 35,3 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 5
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 13
- Formalladung
- 0
- Komplexität
- 176
Physikochemische Eigenschaften
- Siedepunkt
- 230.2 · 230.2±35.0 °C(Predicted)
- Dichte
- 1.726 · 1.726±0.06 g/cm3(Predicted)
- storage temp.
- Keep in dark place,Inert atmosphere,Room temperature
- pka
- 1.38 · 1.38±0.10(Predicted)
- Aggregatzustand
- liquid
- Farbe
- Pale yellow
- InChI
- InChI=1S/C7H5BrF3NO/c8-4-1-2-6(5(12)3-4)13-7(9,10)11/h1-3H,12H2
- InChIKey
- FOJWHUFRHXEUBA-UHFFFAOYSA-N
- SMILES
- C1(N)=CC(Br)=CC=C1OC(F)(F)F
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H301 (90.3%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P280, P301+P316, P302+P352, P321, P330, P332+P317, P362+P364, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 31 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Sicherheitsdaten
- ridadr
- UN2811
- hs_code
- 2922500090
- hazard_code
- Xi
Chemie und Industrie
Anwendungen
Verwenden5-Bromo-2-(trifluoromethoxy)aniline (5-BTA) is a drug with inhibitory activity against cell proliferation and has been shown to be effective in inhibiting the growth of certain cancer cells, such as those expressing tyrosine kinase isoforms. 5-BTA is also capable of blocking cell proliferation through inhibition of other enzymes (e.g., protein kinases). The oral Bioavailability of 5-BTA has been demonstrated in rats and mice. A2780 cells are human lung cancer cells with mutations in the gene encoding tyrosine kinase. Selectivity for tyrosine kinase isoforms was observed in vitro and in vivo.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Anbieter100 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…